Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Starting soon Not applicable

Pulsed Radiofrequency in Post Herptic Neuralgia

NCT07208032 · tracked via the Priya Life Science Egypt tracker
Phase
Not applicable
Started
2025-10-01
Last updated
2025-10-06

Condition(s) studied

Postherpetic Neuralgia (PHN)

Investigational drug(s) / intervention(s)

Irregular Pulsed Radiofrequency (STP)regular pulsed Radiofrequency

Irregular Pulsed Radiofrequency (STP): Flouroscopic guided irregular pulsed Radiofrequency (STP) for dorsal root ganglion

regular pulsed Radiofrequency: Fluoroscopic guided regular pulsed Radiofrequency for the dorsal root ganglion

Study summary

Comparing between regular pulsed Radiofrequency and irregular pulsed Radiofrequency for treatment of postherpetic neuralgia

Eligibility

Sex
ALL
Min age
—
Max age
—
Healthy volunteers
No
Inclusion Criteria: Patients with Herps Zoster neuralgia lasting more than one month Neck thoracic lumbar ganglion involvement Refractory to conventional therapy Exclusion Criteria: Infection ,tumour at the puncture site Severe cardiovascular or cerebrovascular disease Liver, kidney dysfunction Abnormal coagulation Uncontrolled DM Psychatric diseases Patient refusal

Primary outcome measure(s)

  • Pain level by Numerical Rating Scale — One day , One week , One month ,Three months postprocedure.

Trial sites (2)

FacilityCityRegionStatus
Medical research ethics committee Sohag Sohag Governorate
Medical research ethics committee Sohag Egypt
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07208032 on ClinicalTrials.gov ↗ ← All trials in Egypt